Clinical reference
Antiemetic · 5-HT3 receptor antagonist · Oncology, Hematology, Pediatrics
Dolasetron is a selective 5-HT3 receptor antagonist used for prevention of chemotherapy-induced nausea and vomiting (CINV). Oral formulations: tablets 50 mg; oral suspension 10 mg/mL. For CINV, only the oral route is recommended; IV administration is considered contraindicated due to increased risk of QTc prolongation and is no longer available for this i…